Sansec(688489) 广发证券·2024-09-09 10:37Investment Rating - The report maintains a "Buy" rating for the company, with a target price of 28.76 CNY per share based on a 40x PE ratio for 2024 [3][15]. Core Insights - The company's performance met expectations, with significant revenue growth attributed to the consolidation of Jiangnan Keyou. For H1 2024, revenue reached 169 million CNY, a year-on-year increase of 63.48%, and net profit attributable to shareholders was 14 million CNY, up 35.21% year-on-year [6][11]. - The rapid increase in operating expenses during the business expansion phase has impacted short-term profits. Sales, management, and R&D expenses grew by 80.26%, 38.02%, and 43.98% respectively in H1 2024 [6][12]. - The company continues to lead in innovative applications of cryptographic technology in emerging fields, having fully implemented mainstream post-quantum cryptographic algorithms [6][11]. - The establishment of the Hong Kong subsidiary has led to breakthroughs in overseas business, contributing to new revenue streams [6][11]. Financial Summary - For H1 2024, the company reported a revenue of 169 million CNY, with a net profit of 14 million CNY. In Q2 2024, revenue was 120 million CNY, reflecting a year-on-year growth of 78.06% [6][11]. - The company’s gross margin for H1 2024 was 76.83%, an increase of 5.91 percentage points compared to H1 2023 [8]. - The forecast for revenue from 2024 to 2026 is 509 million CNY, 671 million CNY, and 827 million CNY respectively, with year-on-year growth rates of 41.91%, 31.86%, and 23.17% [12][11]. Business Segment Performance - Revenue from the cryptographic machine segment reached 70.29 million CNY, up 69.45% year-on-year, while the cryptographic system segment generated 38.99 million CNY, a 20.94% increase [7]. - The cryptographic services and other segment saw a remarkable growth of 442.35%, reaching 32.92 million CNY, driven by increasing demand for cryptographic services [11][12]. - The cryptographic chip segment experienced a decline, with revenue dropping 73.48% to 0.15 million CNY [7]. Expense Analysis - The company’s sales expenses for H1 2024 were 55.55 million CNY, a year-on-year increase of 80.26%, primarily due to increased sales management capabilities and the consolidation of Jiangnan Keyou [8][12]. - Management expenses rose to 21.84 million CNY, up 38.02% year-on-year, while R&D expenses reached 52.95 million CNY, a 43.98% increase [8][12]. Cash Flow and Financial Ratios - The net cash flow from operating activities for H1 2024 was -22.04 million CNY, reflecting a 22.22% year-on-year improvement [8][9]. - The company’s projected EPS for 2024, 2025, and 2026 is 0.72 CNY, 1.25 CNY, and 1.75 CNY respectively [11][12]. Valuation - The report suggests a reasonable value of 28.76 CNY per share based on a 40x PE ratio for 2024, reflecting the company's strong growth potential and recent international market expansion [15][11].